Clinical Trials Directory

Trials / Completed

CompletedNCT01767753

IOP Fluctuations in Patients With Primary Open-angle Glaucoma, Before and After Selective Laser Trabeculoplasty

A Prospective, Observational, Open Label Study to Assess the 24-hour IOP Fluctuation Pattern Recorded With SENSIMED Triggerfish® in Patients With Primary Open-angle Glaucoma, Before and After Selective Laser Trabeculoplasty

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
23 (actual)
Sponsor
Sensimed AG · Industry
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

Selective laser trabeculoplasty (SLT) is an increasingly popular treatment modality in early-to-moderate glaucoma patients. SLT has been suggested to reduce IOP more consistently during the nocturnal period than during the diurnal period in a group of medically-treated patients with primary open angle glaucoma (POAG). At present, there is scarce data on SLT effects on the 24-hour IOP pattern in patients with glaucoma and there is no data on the 24-hour effect of SLT in untreated glaucoma patients. The purpose of this study is to assess the changes of IOP over a 24-hour period in patients with glaucoma undergoing SLT.

Conditions

Interventions

TypeNameDescription
DEVICESensimed TriggerfishPortable investigational device using a contact lens sensor that monitors the IOP fluctuation continuously over 24-hours

Timeline

Start date
2012-11-01
Primary completion
2014-07-01
Completion
2014-07-01
First posted
2013-01-14
Last updated
2015-11-17

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01767753. Inclusion in this directory is not an endorsement.